Targeting vascular remodeling to treat pulmonary arterial hypertension

AAR Thompson, A Lawrie - Trends in molecular medicine, 2017 - cell.com
Pulmonary arterial hypertension (PAH) describes a group of conditions with a common
hemodynamic phenotype of increased pulmonary artery pressure, driven by progressive …

Gestational hypoxia and developmental plasticity

CA Ducsay, R Goyal, WJ Pearce… - Physiological …, 2018 - journals.physiology.org
Hypoxia is one of the most common and severe challenges to the maintenance of
homeostasis. Oxygen sensing is a property of all tissues, and the response to hypoxia is …

A microRNA-21–mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis

RY Kim, KP Sunkara, KR Bracke, AG Jarnicki… - Science Translational …, 2021 - science.org
Chronic obstructive pulmonary disease (COPD) is the third leading cause of morbidity and
death worldwide. Inhalation of cigarette smoke (CS) is the major cause in developed …

Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice

JM Aliotta, M Pereira, S Wen, MS Dooner… - Cardiovascular …, 2016 - academic.oup.com
Abstract Aims Extracellular vesicles (EVs) from mice with monocrotaline (MCT)-induced
pulmonary hypertension (PH) induce PH in healthy mice, and the exosomes (EXO) fraction …

In pulmonary arterial hypertension, reduced BMPR2 promotes endothelial-to-mesenchymal transition via HMGA1 and its target slug

RK Hopper, JRAJ Moonen, I Diebold, A Cao… - Circulation, 2016 - Am Heart Assoc
Background—We previously reported high-throughput RNA sequencing analyses that
identified heightened expression of the chromatin architectural factor High Mobility Group AT …

The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes

SC Pugliese, JM Poth, MA Fini… - … of Physiology-Lung …, 2015 - journals.physiology.org
Hypoxic pulmonary hypertension (PH) comprises a heterogeneous group of diseases
sharing the common feature of chronic hypoxia-induced pulmonary vascular remodeling …

[HTML][HTML] Non-coding RNAs: The key detectors and regulators in cardiovascular disease

L Zhu, N Li, L Sun, D Zheng, G Shao - Genomics, 2021 - Elsevier
Cardiovascular disease (CVD) is an important cause of disease-related death worldwide.
One of its main pathological bases is imbalances in gene expression. Non-coding RNAs are …

Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series)

B Ranchoux, LD Harvey, RJ Ayon… - Pulmonary …, 2018 - journals.sagepub.com
Endothelial dysfunction is a major player in the development and progression of vascular
pathology in pulmonary arterial hypertension (PAH), a disease associated with small vessel …

Airway smooth muscle in airway reactivity and remodeling: what have we learned?

YS Prakash - American Journal of Physiology-Lung Cellular …, 2013 - journals.physiology.org
It is now established that airway smooth muscle (ASM) has roles in determining airway
structure and function, well beyond that as the major contractile element. Indeed, changes in …

MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts

D Wang, H Zhang, M Li, MG Frid, AR Flockton… - Circulation …, 2014 - Am Heart Assoc
Rationale: Pulmonary hypertensive remodeling is characterized by excessive proliferation,
migration, and proinflammatory activation of adventitial fibroblasts. In culture, fibroblasts …